دورية أكاديمية

WDHD1 is over‐expressed in nasopharyngeal carcinoma and may control the expression of ITGAV.

التفاصيل البيبلوغرافية
العنوان: WDHD1 is over‐expressed in nasopharyngeal carcinoma and may control the expression of ITGAV.
المؤلفون: Wu, Ji‐Yun, Niu, Yi‐Tong, Huang, Su‐Ning, Tan, Yu‐Min, Yang, Zhen‐Dong, Fang, Ye‐Ying, Jiang, Li, Zhang, Ting‐Ting, Zeng, Xiao‐Fen, Peng, Yun‐Xi, Mo, Miao, Lin, Cai‐Xing, Wei, Zhu‐Xin
المصدر: FEBS Open Bio; Jan2023, Vol. 13 Issue 1, p102-117, 16p
مصطلحات موضوعية: GENE expression, NASOPHARYNX cancer, GENE expression profiling, DNA-binding proteins, CELL cycle
مستخلص: Nasopharyngeal carcinoma (NPC) is a highly metastatic and invasive malignant tumor that originates in the nasopharynx. The DNA‐binding protein WD repeat and HMG‐box DNA‐binding protein 1 (WDHD1) are highly expressed in a variety of tumours, but its expression and mechanism of action in NPC have not been reported to date. To investigate the involvement of WDHD1 in NPC, we first mined databases for the gene expression profile of NPC. Immunohistochemistry (IHC) was performed on 338 cases of NPC and 112 non‐NPC samples to verify the results. We report that the expression of WDHD1 is significantly elevated in NPC. ChIP‐seq was used to show that integrin alpha V (ITGAV) and WDHD1 exhibit a significant binding peak in the promoter region of the ITGAV gene. The expression levels of ITGAV and WDHD1 exhibit a significant positive correlation, and IHC was performed to show that ITGAV is highly expressed in NPC. Expression of ITGAV increased after overexpression of WDHD1, suggesting that ITGAV may be a potential target gene of WDHD1. Pathway analysis showed that both genes were closely related to the cell cycle, and flow cytometry was used to further confirm that decreased expression of WDHD1 significantly increased the number of apoptotic cells. In conclusion, our results suggest that expression of WDHD1 is increased in NPC and is likely to be associated with the NPC cell cycle; thus, we propose that WDHD1 may have the potential as a target gene for primary screening and treatment of NPC. [ABSTRACT FROM AUTHOR]
Copyright of FEBS Open Bio is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:22115463
DOI:10.1002/2211-5463.13519